The role of the tumour suppressor p33ING1b in human neoplasia

Journal of Clinical Pathology

Volumn 56, Issue 7, 2003, Pages 491-496

  Nouman, G S ^a   Anderson, J J ^a   Lunec, J ^b   Angus, B ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; INHIBITOR OF GROWTH PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN P33; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CANCER; CANCER; CARCINOGENESIS; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; COLON CARCINOMA; ESOPHAGUS CARCINOMA; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; HEAD AND NECK CANCER; HUMAN; ING1 GENE; ING2 GENE; ING3 GENE; ING4 GENE; INHIBITION OF GROWTH GENE; MELANOMA; MOLECULAR CLONING; MOUTH CANCER; OVARY CANCER; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENESCENCE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL CYCLE PROTEINS; CELL NUCLEUS; CHROMATIN; CYTOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOMA; MUTATION; NEOPLASMS; NUCLEAR PROTEINS; PROTEINS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

EID: 0038006271     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.7.491     Document Type: Review

References (68)

1. Hussain SP, Hofseth IJ, Harris CC. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment. Lung Cancer 2001;34(suppl 2):S7-15.
2. Uhlmann EJ, Gutmann DH. Tumor suppressor gene regulation of cell growth: recent insights into neurofibromatosis 1 and 2 gene function. Cell Biochem Biophys 2001;34:61-78.
3. Garkavtsev I, Kazarov A, Gudkov A, et al. Suppression of the novel growth inhibitor p33(ING1) promotes neoplastic transformation. Nat Genet 1996;14:415-20.
4. Shimada Y, Saito A, Suzuki M, et al. Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressor. Cytogenet Cell Genet 1998;83:232-5.
5. Jager D, Stockert E, Scanlan MJ, et al. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. Cancer Res 1999;59:6197-204.
6. Nagashima M, Shiseki M, Miura K, et al. DNA damage-inducible gene p331NG2 negatively regulates cell proliferation through acetylation of p53. Proc Natl Acad Sci U S A 2001;98:9671-6.
7. Wagner MJ, Gogela-Spehar M, Skirrow RC, et al. Expression of novel ING variants is regulated by thyroid hormone in the Xenopus laevis tadpole. J Biol Chem 2001;276:47013-20.
8. Zeremski M, Hill JE, Kwek SSS, et al. Structure and regulation of the mouse ing1 gene - three alternative transcripts encode two PHD finger proteins that have opposite effects on p53 function. J Biol Chem 1999;274:32172-81.
9. Ha S, Lee S, Chung M, et al. Mouse ING1 homologue, a protein interacting with A1, enhances cell death and is inhibited by A1 in mammary epithelial cells. Cancer Res 2002;62:1275-8.
10. Nagy PL, Griesenbeck J, Kornberg RD, et al. A trithorax-group complex purified from Saccharomyces cerevisiae is required for methylation of histone H3. Proc Natl Acad Sci U S A 2002;99:90-4.
11. Loewith R, Meijer M, Lees-Miller SP, et al. Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities. Mol Cell Biol 2000;20:3807-16.
12. Choy JS, Tobe BT, Huh JH, et al. Yng2p-dependent NuA4 histone H4 acetylation activity is required for mitotic and meiotic progression. J Biol Chem 2001;276:43653-62.
13. Garkavtsev I, Demetrick D, Riabowol K. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1). Cytogenet Cell Genet 1997;76:176-8.
14. Zeremski M, Horrigan SK, Grigorian IA, et al. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34. Somat Cell Mol Genet 1997;23:233-6.
15. Kawaji H, Schonbach C, Matsuo Y, et al. Exploration of novel motifs derived from mouse cDNA sequences. Genome Res 2002;12:367-78.
16. Nolte D, Muller U. Human O-G1cNAc transferase (OGT): genomic structure, analysis of splice variants, fine mopping in Xq13.1. Mamm Genome 2002;13:62-4.
17. Cheung KJ, Li G. The tumor suppressor ing1: structure and function. Exp Cell Res 2001;268:1-6.
18. Gunduz M, Ouchida M, Fukushima K, et al. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res 2000;60:3143-6.
19. Baranova AV, Ivanov DV, Makeeva NV, et al. Genomic organization of a tumor growth inhibitor gene ING1. Mol Biol 2000;34:232-6.
20. Garkavtsev I. Suppression of the novel growth inhibitor p33(ING1) promotes neoplastic transformation. Nat Genet 1999;23:373.
21. Saito A, Furukawa T, Fukushige S, et al. p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1. J Hum Genet 2000;45:177-81.
22. Nouman GS, Angus B, Lunec J, et al. Comparative assessment of expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues. Hybridoma 2002;21:1-10.
23. Skowyra D, Zeremski M, Neznanov N, et al. Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. J Biol Chem 2001;276:8734-9.
24. Scott M, Boisvert FM, Vieyra D, et al. UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences. Nucl Acids Res 2001;29:2052-8.
25. Boland D, Olineck V, Bonnefin P, et al. A panel of CAb antibodies recognize endogenous and ectopically expressed ING1 protein. Hybridoma 2000;19:161-5.
26. Garkavtsev I, Riabowol K. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33(ING1) candidate tumor suppressor. Mol Cell Biol 1997;17:2014-19.
27. Garkavtsev I, Boland D, Mai J, et al. Specific monoclonal antibody raised against the p33(ING1) tumor suppressor. Hybridoma 1997;16:537-40.
28. Scott M, Bonnefin P, Vieyra D, et al. UV-induced binding of ING1 to PCNA regulates the induction of apoptosis. J Cell Sci 2001;114:3455-62.
29. Helbing CC, Veillette C, Riabowol K, et al. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res 1997;57:1255-8.
30. Garkavtsev I, Grigorian IA, Ossovskaya VS, et al. The candidate tumour suppressor p33(ING1) cooperates with p53 in cell growth control. Nature 1998;391:295-8.
31. Garkavtsev I, Hull C, Riabowol K. Molecular aspects of the relationship between cancer and aging: tumor suppressor activity during cellular senescence. Exp Gerontol 1998;33:81-94.
32. Turovets NA, Agapova LS, Kopnin PB, et al. Inactivation of p33(ING1) tumor suppressor affects the function of the cell cycle "checkpoints" and stability of the genome. Russian J of Genet 2000;36:305-12.
33. Shimada H, Liu TL, Ochiai T, et al. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells. Oncogene 2002;21:1208-16.
34. Oren M. Tumor suppressors. Teaming up to restrain cancer. Nature 1998;391:233-4.
35. Tokunaga E, Maehara Y, Oki E, et al. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers. Cancer Lett 2000;152:15-22.
36. Shinoura N, Muramatsu Y, Nishimura M, et al. Adenovirus-mediated transfer of p33(ING1) with p53 drastically augments apoptosis in gliomas. Cancer Res 1999;59:5521-8.
37. Nourani A, Doyon Y, Utley RT, et al. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex. Mol Cell Biol 2001;21:7629-40.
38. Nourani A, Doyon Y, Utley R, et al. The yeast nua4 acetyltransferase complex contains an ing1 family growth regulator and is important for pho5 expression. Yeast 2001;18:S63-3.
39. Vladimir S, Spiegelman TJS. The role of novel tumor suppressor ING1 in mouse carcinogenesis. Toxicol Pathol 1999;27:729-30.
40. Cheung KJJ, Bush JA, Jia W, et al. Expression of the novel tumour suppressor p33(ING1) is independent of p53. Br J Cancer 2000;83:1468-72.
41. Chen L, Matsubara N, Yoshino T, et al. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer. Cancer Res 2001;61:4345-9.
42. Cheung KJ, Mitchell D, Lin P, et al. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA. Cancer Res 2001;61:4974-7.
43. Kuzmichev A, Zhang Y, Erdjument-Bromage H, et al. Role of the Sin3-histone deacetytase complex in growth regulation by the candidate tumor suppressor p33(ING1). Mol Cell Biol 2002;22:835-48.
44. Takahashi M, Seki N, Ozaki T, et al. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial celt line NMuMG. Cancer Res 2002;62:2203-9.
45. Takahashi R. Role of the RB gene in carcinogenesis. Hum Cell 1993;6:260-5.
46. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90.
47. Motomura K, Nishisho I, Takai S, et al. Loss of alleles at loci on chromosome 13 in human primary gastric cancers. Genomics 1988;2:180-4.
48. Huang TH, Quesenberry JT, Martin MB, et al. Loss of heterozygosity detected in formalin-fixed, paraffin-embedded tissue of colorectal carcinoma using a microsatellite located within the deleted in colorectal carcinoma gene. Diagn Mol Pathol 1993;2:90-3.
49. Anglard P, Tory K, Brauch H, et al. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 1991;51:1071-7.
50. Cairns P, Proctor AJ, Knowles MA. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 1991;6:2305-9.
51. Borg A, Zhang QX, Olsson H, et al. Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis. Genes Chromosomes Cancer 1992;5:311-20.
52. Shenson DL, Gallion HH, Powell DE, et al. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer 1995;76:650-7.
53. Reissmann PT, Koga H, Takahashi R, et al. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The lung cancer study group. Oncogene 1993;8:1913-19.
54. Mitelman F, Heim S. Chromosome abnormalities in cancer. Cancer Detect Prev 1990;14:527-37.
55. Maestro R, Dolcetti R. Oncogenes and tumor suppressor genes in head and neck squamous cell carcinomas. Acta Otorhinolaryngol Ital 1996;16:21-6.
56. Ito K, Kinjo K, Nakazato T, et al. Expression and sequence analyses of p33(ING1) gene in myeloid leukemia. Am J Hematol 2002;69:141-3.
57. Oki E, Maehara Y, Tokunaga E, et al. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Cancer Lett 1999;147:157-62.
58. Sanchez-Cespedes M, Okami K, Cairns P, et al. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions. Genes Chromosomes Cancer 2000;27:319-22.
59. Campos EI, Cheung KJ, Murray A, et al. The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines. Br J Dermatol 2002;146:574-80.
60. Toyama T, Iwase H, Watson P, et al. Suppression of ING1 expression in sporadic breast cancer. Oncogene 1999;18:5187-93.
61. Sarelo AI, Farmery SM, Markham AF, et al. The candidate tumour suppressor gene, ING1, is retained in colorectal carcinomas. Eur J Cancer 1999;35:1264-7.
62. Krishnamurthy J, Kannan K, Feng J, et al. Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma. Oral Oncol 2001;37:222-4.
63. Ohmori M, Nagai M, Tasaka T, et al. Decreased expression of p33ING1 mRNA in lymphoid malignancies. Am J Hematol 1999;62:118-19.
64. Nouman GS, Anderson JJ, Mathers ME, et al. Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions. Histopathology 2002;40:360-6.
65. Nouman GS, Anderson JJ, Wood KW, et al. Loss of nuclear expression of the inhibitor of growth p33ING1b in childhood acute lymphoblastic leukaemia. J Clin Pathol 2002;55:1-6.
66. Ahmed IAM, Nouman GS, Lunec J, et al. Expression of p33/ING1 gene products in colorectal cancer and its correlation with survival. Gastroenterology 2001;120:1548.
67. Nouman GS, Anderson JJ, Crosier S, et al. p33(ING1b) tumour suppresser protein expression in thyroid lesions determined by immunohistochemistry. J Pathol 2001;195:37A.
68. Sager R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci U S A 1997;94:952-5.